FBP Antibodies

Santa Cruz Biotechnology delivers a wide array of FBP monoclonal antibodies for the specific detection and analysis of fructose-1,6-bisphosphatase (FBP). FBP Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fructose-1,6-bisphosphatase plays a crucial role in gluconeogenesis, the metabolic pathway that generates glucose from non-carbohydrate substrates, making it essential for maintaining blood sugar levels during fasting. Dysregulation of FBP can lead to metabolic disorders, highlighting its significance in both basic research and clinical studies. Understanding the function and regulation of fructose-1,6-bisphosphatase is vital for developing therapeutic strategies for conditions such as diabetes and obesity. Research focused on FBP expression patterns helps illuminate key aspects of cellular metabolism and energy homeostasis. Investigating FBP activity provides valuable insights into metabolic pathway regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of metabolic diseases and potential treatments.